Altamira Therapeutics Ltd. Equity Attributable To Owners Of Parent
Altamira Therapeutics Ltd. (CYTOF) had Equity Attributable To Owners Of Parent of $4.07 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:EquityAttributableToOwnersOfParent · last filed 2025-08-29
- 2023-12-31: Equity Attributable To Owners Of Parent 6.46M CHF.
- 2022-12-31: Equity Attributable To Owners Of Parent -8.31M CHF.
- 2021-12-31: Equity Attributable To Owners Of Parent 13.04M CHF; Equity Attributable To Owners Of Parent as first filed 12.70M CHF.
- 2020-12-31: Equity Attributable To Owners Of Parent 16.77M CHF.
CHF
| Period end | Equity Attributable To Owners Of Parent | Equity Attributable To Owners Of Parent as first filed |
|---|---|---|
| 2023-12-31 | 6.46M CHF 20-F/A · filed 2024-04-22 | |
| 2022-12-31 | -8.31M CHF 20-F/A · filed 2024-04-22 | |
| 2021-12-31 | 13.04M CHF 20-F · filed 2023-05-16 | 12.70M CHF 20-F · filed 2022-04-12 |
| 2020-12-31 | 16.77M CHF 20-F · filed 2022-04-12 |
USD
| Period end | Equity Attributable To Owners Of Parent |
|---|---|
| 2025-06-30 | $4.07M 6-K · filed 2025-08-29 |
| 2024-12-31 | $6.57M 6-K · filed 2025-08-29 |
| 2023-12-31 | $7.68M 20-F · filed 2025-04-30 |
| 2023-01-01 | -$8.99M 20-F · filed 2025-04-30 |
| 2022-12-31 | -$8.30M 6-K · filed 2023-09-12 |